 GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 06, 2021 GLOBE NEWSWIRE -- Applied Genetic Technologies Corporation Nasdaq: AGTC, a biotechnology company focused on developing adeno-associated virus AAV based gene therapies for the treatment of rare inherited diseases, today announced that Sue Washer, President Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Virtual BioConnect Conference held January 11 14, 2021. 